See more : China Meheco Group Co., Ltd. (600056.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Ingevity Corporation (NGVT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ingevity Corporation, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- ConnectOne Bancorp, Inc. (CNOBP) Income Statement Analysis – Financial Results
- Zhejiang Guanghua Technology Co., Ltd. (001333.SZ) Income Statement Analysis – Financial Results
- Riverview Financial Corporation (RIVE) Income Statement Analysis – Financial Results
- Avolta AG (DFRYF) Income Statement Analysis – Financial Results
- ACDC Metals Limited (ADC.AX) Income Statement Analysis – Financial Results
Ingevity Corporation (NGVT)
About Ingevity Corporation
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.69B | 1.67B | 1.39B | 1.22B | 1.29B | 1.13B | 972.40M | 908.30M | 968.00M | 1.04B | 980.00M | 939.00M |
Cost of Revenue | 1.22B | 1.10B | 878.70M | 750.60M | 810.90M | 716.80M | 643.40M | 633.90M | 687.00M | 718.00M | 685.00M | 642.00M |
Gross Profit | 471.90M | 570.10M | 512.80M | 465.50M | 482.00M | 416.80M | 329.00M | 274.40M | 281.00M | 323.00M | 295.00M | 297.00M |
Gross Profit Ratio | 27.89% | 34.17% | 36.85% | 38.28% | 37.28% | 36.77% | 33.83% | 30.21% | 29.03% | 31.03% | 30.10% | 31.63% |
Research & Development | 31.80M | 30.30M | 26.30M | 22.60M | 19.70M | 21.50M | 19.80M | 7.60M | 6.90M | 8.00M | 11.00M | 9.00M |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 132.40M | 106.40M | 114.00M | 114.00M | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 141.80M | 198.80M | 179.30M | 149.40M | 163.10M | 132.40M | 106.40M | 114.00M | 114.00M | 112.00M | 103.00M | 95.00M |
Other Expenses | 0.00 | 1.70M | -79.90M | 4.10M | 4.30M | -1.00M | -500.00K | 3.20M | 10.00M | 4.00M | 5.00M | -1.00M |
Operating Expenses | 183.70M | 229.10M | 205.60M | 172.00M | 182.80M | 153.90M | 126.20M | 114.00M | 114.00M | 112.00M | 103.00M | 95.00M |
Cost & Expenses | 1.39B | 1.33B | 1.08B | 922.60M | 993.70M | 870.70M | 769.60M | 747.90M | 801.00M | 830.00M | 788.00M | 737.00M |
Interest Income | 6.30M | 7.50M | 4.40M | 4.90M | 7.70M | 3.40M | 2.30M | 1.40M | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 93.30M | 54.30M | 47.70M | 42.20M | 46.90M | 29.80M | 15.80M | 19.30M | 21.00M | 16.00M | 13.00M | 12.00M |
Depreciation & Amortization | 122.80M | 124.90M | 127.20M | 118.20M | 85.00M | 57.00M | 40.40M | 38.80M | 35.00M | 33.00M | 33.00M | 32.00M |
EBITDA | 224.60M | 456.30M | 337.20M | 397.80M | 412.90M | 319.80M | 243.10M | 199.20M | 199.90M | 252.00M | 230.00M | 233.00M |
EBITDA Ratio | 13.27% | 27.06% | 24.23% | 32.71% | 31.94% | 23.10% | 20.80% | 18.17% | 21.90% | 23.82% | 23.47% | 24.81% |
Operating Income | 288.20M | 342.70M | 227.30M | 297.60M | 327.90M | 262.90M | 202.80M | 160.40M | 167.00M | 211.00M | 192.00M | 202.00M |
Operating Income Ratio | 17.03% | 20.54% | 16.33% | 24.47% | 25.36% | 23.19% | 20.86% | 17.66% | 17.25% | 20.27% | 19.59% | 21.51% |
Total Other Income/Expenses | -298.30M | -71.40M | -144.40M | -58.40M | -71.30M | -41.10M | -28.00M | -73.40M | -28.80M | -8.90M | -8.00M | -13.00M |
Income Before Tax | -10.10M | 269.60M | 162.80M | 235.10M | 227.90M | 221.80M | 174.80M | 87.00M | 138.00M | 203.00M | 184.00M | 189.00M |
Income Before Tax Ratio | -0.60% | 16.16% | 11.70% | 19.33% | 17.63% | 19.57% | 17.98% | 9.58% | 14.26% | 19.50% | 18.78% | 20.13% |
Income Tax Expense | -4.70M | 58.00M | 44.70M | 48.90M | 44.20M | 40.00M | 29.80M | 42.60M | 53.00M | 70.00M | 66.00M | 67.00M |
Net Income | -5.40M | 211.60M | 118.10M | 181.40M | 183.70M | 169.10M | 126.30M | 35.20M | 80.00M | 129.00M | 119.00M | 119.00M |
Net Income Ratio | -0.32% | 12.68% | 8.49% | 14.92% | 14.21% | 14.92% | 12.99% | 3.88% | 8.26% | 12.39% | 12.14% | 12.67% |
EPS | -0.15 | 5.54 | 2.97 | 4.39 | 4.39 | 4.03 | 3.00 | 0.83 | 1.89 | 3.07 | 2.83 | 2.83 |
EPS Diluted | -0.15 | 5.50 | 2.95 | 4.37 | 4.35 | 3.97 | 2.97 | 0.83 | 1.89 | 3.07 | 2.83 | 2.83 |
Weighted Avg Shares Out | 36.50M | 38.18M | 39.82M | 41.33M | 41.80M | 42.00M | 42.10M | 42.10M | 42.07M | 42.07M | 42.07M | 42.07M |
Weighted Avg Shares Out (Dil) | 36.50M | 38.47M | 40.06M | 41.55M | 42.20M | 42.60M | 42.50M | 42.30M | 42.07M | 42.07M | 42.07M | 42.07M |
Why Is Ingevity (NGVT) Up 14.6% Since Last Earnings Report?
Should Value Investors Buy Ingevity (NGVT) Stock?
Ingevity Corporation (NGVT) Q3 2024 Earnings Call Transcript
Ingevity's Earnings Beat Estimates in Q3, Revenues Down Y/Y
Ingevity reports third quarter 2024 financial results
Ingevity updates third-quarter 2024 earnings release and webcast dates
Ingevity (NGVT) Soars 12.0%: Is Further Upside Left in the Stock?
AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday
Ingevity announces CEO transition as Fortson departs company; Fernandez-Moreno appointed as interim president and CEO
Ingevity to Launch Capa HS at the 2024 Polyurethanes Conference
Source: https://incomestatements.info
Category: Stock Reports